SEC Form 4 · accession 0001203311-16-000149
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaughn B Himes
Officer — EVP, Proc Svcs & Tech Ops
Period of report
Aug 31, 2016
Accepted (ET)
Sep 1, 2016 · 8:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 31, 2016 | A | 9,600 | $0.00 | A | 135,379 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2Restricted stock units shall vest in full three (3) years from September 1, 2016.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.